Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol

The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis. Atenolol was given orally for at least 1 week before the study to maintain the heart rate between 5...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular drugs and therapy 1997-04, Vol.11 (2), p.139-147
Hauptverfasser: ROCHA, P, PATHE, M, BERNAUD, C, ZANNIER, D, BARON, B, MARCHAND, X, HOTTON, J.-M, KAHN, J.-C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 147
container_issue 2
container_start_page 139
container_title Cardiovascular drugs and therapy
container_volume 11
creator ROCHA, P
PATHE, M
BERNAUD, C
ZANNIER, D
BARON, B
MARCHAND, X
HOTTON, J.-M
KAHN, J.-C
description The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis. Atenolol was given orally for at least 1 week before the study to maintain the heart rate between 50 and 60 beats/min. All patients were given two doses of 10 mg of amlodipine, or 10 ml of a placebo twice, in i.v. infusion lasting 2 minutes each. Hemodynamic data were collected during the control period and 15 minutes after each of the two amlodipine or placebo infusions. At the time of the last measurements, 15 minutes after the second amlodipine or placebo infusion, the plasma amlodipine level was 31 +/- 16 micrograms/l and the plasma atenolol level was 773 +/- 564 mu/l in the amlodipine group versus 795 +/- 916 micrograms/l in the placebo group. There were no chronotropic, dromotropic, or inotropic effects. The main hemodynamic effect was a fall in systemic vascular resistance (1548 +/- 591 dynes.sec.cm-5 to 1176 +/- 526 dynes.sec.cm-5, p = 0.045) with decreases in aortic pressure and in the left ventricular stroke work index. The left ventricular ejection fraction was 51 +/- 12% in the placebo group and 56 +/- 15% in the amlodipine group (ns) during the control period, and did not change after infusion of placebo or amlodipine. Left ventricular compliance seemed to be enhanced by amlodipine, because the end-diastolic left ventricular volume index rose from 82 +/- 11 ml/m2 to 87 +/- 11 ml/m2 (p = 0.026) 15 minutes after the beginning of the second infusion of 10 mg of amlodipine, without any change in end-diastolic left ventricular pressure. Intravenous infusion of 20 mg of amlodipine is well tolerated 15 days after acute myocardial infarction in normotensive patients without deeply depressed left ventricular systolic function and chronically treated with atenolol. The main hemodynamic effects observed are potentially useful for such patients.
doi_str_mv 10.1023/A:1007732830753
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_9140691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9140691</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-6e29e8205bdc3bd04b387784e2ab38a6c0ffa5d708d300eb39ada3b7e1cf222d3</originalsourceid><addsrcrecordid>eNo9kE1LxDAURYMo4zi6diVk4bb6krRN624Y_IIBN7oeXpMXJtImpc0oBX-8BQdX98A93MVl7FrAnQCp7tcPAkBrJSsFulAnbCkKrTItc3HKllBLyJSE8pxdjOMnzGpdVwu2qEUOZS2W7GdtDon4nrpop4CdN5ycI5NGHh3Hro3W9z4QFwW3OI0cXaKBI--maHCwHlvug8PBJB_DjDzEoYuJwui_iPeYPIV5LA2EiSz_9mnPZwqxje0lO3PYjnR1zBX7eHp837xk27fn1816m_VSFSkrSdZUSSgaa1RjIW9UpXWVk8SZsDTgHBZWQ2UVADWqRouq0SSMk1JatWI3f7v9oenI7vrBdzhMu-MLc3977HE02LoBg_HjvybLEopCql_31W5R</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>ROCHA, P ; PATHE, M ; BERNAUD, C ; ZANNIER, D ; BARON, B ; MARCHAND, X ; HOTTON, J.-M ; KAHN, J.-C</creator><creatorcontrib>ROCHA, P ; PATHE, M ; BERNAUD, C ; ZANNIER, D ; BARON, B ; MARCHAND, X ; HOTTON, J.-M ; KAHN, J.-C</creatorcontrib><description>The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis. Atenolol was given orally for at least 1 week before the study to maintain the heart rate between 50 and 60 beats/min. All patients were given two doses of 10 mg of amlodipine, or 10 ml of a placebo twice, in i.v. infusion lasting 2 minutes each. Hemodynamic data were collected during the control period and 15 minutes after each of the two amlodipine or placebo infusions. At the time of the last measurements, 15 minutes after the second amlodipine or placebo infusion, the plasma amlodipine level was 31 +/- 16 micrograms/l and the plasma atenolol level was 773 +/- 564 mu/l in the amlodipine group versus 795 +/- 916 micrograms/l in the placebo group. There were no chronotropic, dromotropic, or inotropic effects. The main hemodynamic effect was a fall in systemic vascular resistance (1548 +/- 591 dynes.sec.cm-5 to 1176 +/- 526 dynes.sec.cm-5, p = 0.045) with decreases in aortic pressure and in the left ventricular stroke work index. The left ventricular ejection fraction was 51 +/- 12% in the placebo group and 56 +/- 15% in the amlodipine group (ns) during the control period, and did not change after infusion of placebo or amlodipine. Left ventricular compliance seemed to be enhanced by amlodipine, because the end-diastolic left ventricular volume index rose from 82 +/- 11 ml/m2 to 87 +/- 11 ml/m2 (p = 0.026) 15 minutes after the beginning of the second infusion of 10 mg of amlodipine, without any change in end-diastolic left ventricular pressure. Intravenous infusion of 20 mg of amlodipine is well tolerated 15 days after acute myocardial infarction in normotensive patients without deeply depressed left ventricular systolic function and chronically treated with atenolol. The main hemodynamic effects observed are potentially useful for such patients.</description><identifier>ISSN: 0920-3206</identifier><identifier>EISSN: 1573-7241</identifier><identifier>DOI: 10.1023/A:1007732830753</identifier><identifier>PMID: 9140691</identifier><identifier>CODEN: CDTHET</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Acute Disease ; Adrenergic beta-Antagonists - adverse effects ; Adrenergic beta-Antagonists - blood ; Adrenergic beta-Antagonists - therapeutic use ; Amlodipine - adverse effects ; Amlodipine - blood ; Amlodipine - therapeutic use ; Antianginal agents. Coronary vasodilator agents ; Antihypertensive Agents - adverse effects ; Antihypertensive Agents - blood ; Antihypertensive Agents - therapeutic use ; Atenolol - adverse effects ; Atenolol - blood ; Atenolol - therapeutic use ; Biological and medical sciences ; Cardiovascular system ; Female ; Hemodynamics - drug effects ; Humans ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - drug therapy ; Myocardial Infarction - physiopathology ; Pharmacology. Drug treatments</subject><ispartof>Cardiovascular drugs and therapy, 1997-04, Vol.11 (2), p.139-147</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2660552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9140691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ROCHA, P</creatorcontrib><creatorcontrib>PATHE, M</creatorcontrib><creatorcontrib>BERNAUD, C</creatorcontrib><creatorcontrib>ZANNIER, D</creatorcontrib><creatorcontrib>BARON, B</creatorcontrib><creatorcontrib>MARCHAND, X</creatorcontrib><creatorcontrib>HOTTON, J.-M</creatorcontrib><creatorcontrib>KAHN, J.-C</creatorcontrib><title>Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol</title><title>Cardiovascular drugs and therapy</title><addtitle>Cardiovasc Drugs Ther</addtitle><description>The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis. Atenolol was given orally for at least 1 week before the study to maintain the heart rate between 50 and 60 beats/min. All patients were given two doses of 10 mg of amlodipine, or 10 ml of a placebo twice, in i.v. infusion lasting 2 minutes each. Hemodynamic data were collected during the control period and 15 minutes after each of the two amlodipine or placebo infusions. At the time of the last measurements, 15 minutes after the second amlodipine or placebo infusion, the plasma amlodipine level was 31 +/- 16 micrograms/l and the plasma atenolol level was 773 +/- 564 mu/l in the amlodipine group versus 795 +/- 916 micrograms/l in the placebo group. There were no chronotropic, dromotropic, or inotropic effects. The main hemodynamic effect was a fall in systemic vascular resistance (1548 +/- 591 dynes.sec.cm-5 to 1176 +/- 526 dynes.sec.cm-5, p = 0.045) with decreases in aortic pressure and in the left ventricular stroke work index. The left ventricular ejection fraction was 51 +/- 12% in the placebo group and 56 +/- 15% in the amlodipine group (ns) during the control period, and did not change after infusion of placebo or amlodipine. Left ventricular compliance seemed to be enhanced by amlodipine, because the end-diastolic left ventricular volume index rose from 82 +/- 11 ml/m2 to 87 +/- 11 ml/m2 (p = 0.026) 15 minutes after the beginning of the second infusion of 10 mg of amlodipine, without any change in end-diastolic left ventricular pressure. Intravenous infusion of 20 mg of amlodipine is well tolerated 15 days after acute myocardial infarction in normotensive patients without deeply depressed left ventricular systolic function and chronically treated with atenolol. The main hemodynamic effects observed are potentially useful for such patients.</description><subject>Acute Disease</subject><subject>Adrenergic beta-Antagonists - adverse effects</subject><subject>Adrenergic beta-Antagonists - blood</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Amlodipine - adverse effects</subject><subject>Amlodipine - blood</subject><subject>Amlodipine - therapeutic use</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Antihypertensive Agents - adverse effects</subject><subject>Antihypertensive Agents - blood</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Atenolol - adverse effects</subject><subject>Atenolol - blood</subject><subject>Atenolol - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Female</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><issn>0920-3206</issn><issn>1573-7241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAURYMo4zi6diVk4bb6krRN624Y_IIBN7oeXpMXJtImpc0oBX-8BQdX98A93MVl7FrAnQCp7tcPAkBrJSsFulAnbCkKrTItc3HKllBLyJSE8pxdjOMnzGpdVwu2qEUOZS2W7GdtDon4nrpop4CdN5ycI5NGHh3Hro3W9z4QFwW3OI0cXaKBI--maHCwHlvug8PBJB_DjDzEoYuJwui_iPeYPIV5LA2EiSz_9mnPZwqxje0lO3PYjnR1zBX7eHp837xk27fn1816m_VSFSkrSdZUSSgaa1RjIW9UpXWVk8SZsDTgHBZWQ2UVADWqRouq0SSMk1JatWI3f7v9oenI7vrBdzhMu-MLc3977HE02LoBg_HjvybLEopCql_31W5R</recordid><startdate>19970401</startdate><enddate>19970401</enddate><creator>ROCHA, P</creator><creator>PATHE, M</creator><creator>BERNAUD, C</creator><creator>ZANNIER, D</creator><creator>BARON, B</creator><creator>MARCHAND, X</creator><creator>HOTTON, J.-M</creator><creator>KAHN, J.-C</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19970401</creationdate><title>Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol</title><author>ROCHA, P ; PATHE, M ; BERNAUD, C ; ZANNIER, D ; BARON, B ; MARCHAND, X ; HOTTON, J.-M ; KAHN, J.-C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-6e29e8205bdc3bd04b387784e2ab38a6c0ffa5d708d300eb39ada3b7e1cf222d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Acute Disease</topic><topic>Adrenergic beta-Antagonists - adverse effects</topic><topic>Adrenergic beta-Antagonists - blood</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Amlodipine - adverse effects</topic><topic>Amlodipine - blood</topic><topic>Amlodipine - therapeutic use</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Antihypertensive Agents - adverse effects</topic><topic>Antihypertensive Agents - blood</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Atenolol - adverse effects</topic><topic>Atenolol - blood</topic><topic>Atenolol - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Female</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ROCHA, P</creatorcontrib><creatorcontrib>PATHE, M</creatorcontrib><creatorcontrib>BERNAUD, C</creatorcontrib><creatorcontrib>ZANNIER, D</creatorcontrib><creatorcontrib>BARON, B</creatorcontrib><creatorcontrib>MARCHAND, X</creatorcontrib><creatorcontrib>HOTTON, J.-M</creatorcontrib><creatorcontrib>KAHN, J.-C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cardiovascular drugs and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ROCHA, P</au><au>PATHE, M</au><au>BERNAUD, C</au><au>ZANNIER, D</au><au>BARON, B</au><au>MARCHAND, X</au><au>HOTTON, J.-M</au><au>KAHN, J.-C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol</atitle><jtitle>Cardiovascular drugs and therapy</jtitle><addtitle>Cardiovasc Drugs Ther</addtitle><date>1997-04-01</date><risdate>1997</risdate><volume>11</volume><issue>2</issue><spage>139</spage><epage>147</epage><pages>139-147</pages><issn>0920-3206</issn><eissn>1573-7241</eissn><coden>CDTHET</coden><abstract>The acute hemodynamic effects of 20 mg iv amlodipine were evaluated in a placebo-controlled study in 16 normotensive patients 15 +/- 1 days after an acute myocardial infarction by covariance analysis. Atenolol was given orally for at least 1 week before the study to maintain the heart rate between 50 and 60 beats/min. All patients were given two doses of 10 mg of amlodipine, or 10 ml of a placebo twice, in i.v. infusion lasting 2 minutes each. Hemodynamic data were collected during the control period and 15 minutes after each of the two amlodipine or placebo infusions. At the time of the last measurements, 15 minutes after the second amlodipine or placebo infusion, the plasma amlodipine level was 31 +/- 16 micrograms/l and the plasma atenolol level was 773 +/- 564 mu/l in the amlodipine group versus 795 +/- 916 micrograms/l in the placebo group. There were no chronotropic, dromotropic, or inotropic effects. The main hemodynamic effect was a fall in systemic vascular resistance (1548 +/- 591 dynes.sec.cm-5 to 1176 +/- 526 dynes.sec.cm-5, p = 0.045) with decreases in aortic pressure and in the left ventricular stroke work index. The left ventricular ejection fraction was 51 +/- 12% in the placebo group and 56 +/- 15% in the amlodipine group (ns) during the control period, and did not change after infusion of placebo or amlodipine. Left ventricular compliance seemed to be enhanced by amlodipine, because the end-diastolic left ventricular volume index rose from 82 +/- 11 ml/m2 to 87 +/- 11 ml/m2 (p = 0.026) 15 minutes after the beginning of the second infusion of 10 mg of amlodipine, without any change in end-diastolic left ventricular pressure. Intravenous infusion of 20 mg of amlodipine is well tolerated 15 days after acute myocardial infarction in normotensive patients without deeply depressed left ventricular systolic function and chronically treated with atenolol. The main hemodynamic effects observed are potentially useful for such patients.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>9140691</pmid><doi>10.1023/A:1007732830753</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-3206
ispartof Cardiovascular drugs and therapy, 1997-04, Vol.11 (2), p.139-147
issn 0920-3206
1573-7241
language eng
recordid cdi_pubmed_primary_9140691
source MEDLINE; SpringerNature Journals
subjects Acute Disease
Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - blood
Adrenergic beta-Antagonists - therapeutic use
Amlodipine - adverse effects
Amlodipine - blood
Amlodipine - therapeutic use
Antianginal agents. Coronary vasodilator agents
Antihypertensive Agents - adverse effects
Antihypertensive Agents - blood
Antihypertensive Agents - therapeutic use
Atenolol - adverse effects
Atenolol - blood
Atenolol - therapeutic use
Biological and medical sciences
Cardiovascular system
Female
Hemodynamics - drug effects
Humans
Male
Medical sciences
Middle Aged
Myocardial Infarction - drug therapy
Myocardial Infarction - physiopathology
Pharmacology. Drug treatments
title Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T16%3A07%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20hemodynamic%20effects%20of%20amlodipine%2015%20days%20after%20a%20myocardial%20infarction%20in%20normotensive%20patients%20treated%20with%20atenolol&rft.jtitle=Cardiovascular%20drugs%20and%20therapy&rft.au=ROCHA,%20P&rft.date=1997-04-01&rft.volume=11&rft.issue=2&rft.spage=139&rft.epage=147&rft.pages=139-147&rft.issn=0920-3206&rft.eissn=1573-7241&rft.coden=CDTHET&rft_id=info:doi/10.1023/A:1007732830753&rft_dat=%3Cpubmed_pasca%3E9140691%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9140691&rfr_iscdi=true